Mansoor-Ali Vaali-Mohammed
Mansoor-Ali Vaali-Mohammed is an expert in Oncology at King Saud University (Saudi Arabia). Mansoor-Ali Vaali-Mohammed has authored 31 publications, the most recent in 2026. SLR score: 89 (community average: 125). How the SLR is computed.
LeadR Profile
Oncology
Subspecialties: Biochemistry - Pharmacy
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Short Biography
I serve as a Senior Scientist specializing in colorectal cancer, with a PhD focused on therapeutic drug screening, mRNA regulation, apoptosis mechanisms, and proteomic profiling. I have trained and guided five colorectal fellows as well as two PhD and master's students.
Organizations
Career arc: 2005 - 2026
Number : 31
Citations
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Comparative molecular analysis of colorectal cancer in Saudi Arabia: distinct genetic alterations and clinical features. PMID 42147237 — neoplasms, colorectal neoplasms, mutation | Front Oncol | 2026 | 0 |
| Herbal Melanin Inhibits Colorectal Cancer Cell Motility, Invasiveness, and Epithelial-Mesenchymal Transition, Associated with u-PAR Downregulation Through JNK and ERK Pathways. PMID 42042013 — cells, melanins, epithelial-mesenchymal transition, neoplasms, cadherins, cell line, mitogen-activated protein kinase kinases, urokinase-type plasminogen activator, receptors, urokinase plasminogen activator, colorectal neoplasms, down-regulation | Curr Issues Mol Biol | 2026 | 0 |
| Natural and Synthetic Compounds Against Colorectal Cancer: An Update of Preclinical Studies in Saudi Arabia. PMID 41149466 — protein kinases, neoplasms, oxazoles, research, colorectal neoplasms, nanotechnology | Curr Oncol | 2025 | 0 |
| Sulfonamide-arylidene hybrids featuring flexible hydrazide and rigid triazole linkers: design, synthesis, and evaluation as carbonic anhydrase inhibitors with anti-breast cancer potential. PMID 40774110 — cells, biochemistry, breast neoplasms, neoplasms, triazoles, breast, carbonic anhydrases, sulfonamides, carbonic anhydrase inhibitors | Bioorg Chem | 2025 | 0 |
| Tumor Necrosis Factor-Alpha's Role in the Pathophysiology of Colon Cancer. PMID 40558596 — tumor necrosis factor-alpha, neoplasms, colon, oxidative stress, necrosis, therapeutics, colonic neoplasms | Diseases | 2025 | 0 |
LeadR Networks
Main global connection map